» Authors » Martin E van Royen

Martin E van Royen

Explore the profile of Martin E van Royen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 7289
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Scholtes M, Akbarzadeh M, Galaras A, Nakauma-Gonzales J, Bazrafshan A, Solanki V, et al.
Cancer Lett . 2025 Feb; 614:217506. PMID: 39892702
Somatic mutations in ARID1A (AT-rich interactive domain-containing protein 1A) are present in approximately 25 % of bladder cancers (BC) and are associated with poor prognosis. With a view to discover...
2.
Rijstenberg L, Harikumar H, Verhoef E, van den Bosch T, Choiniere R, van Royen M, et al.
Histopathology . 2025 Jan; PMID: 39888049
Aims: Intraductal carcinoma (IDC) is an independent pathological parameter for adverse prostate cancer (PCa) outcome. Although most IDC are believed to originate from retrograde spread of established PCa, rare IDC...
3.
Yavuz S, Abraham T, Houtsmuller A, van Royen M
Cells . 2024 Oct; 13(20. PMID: 39451211
The androgen receptor (AR), a member of the nuclear steroid hormone receptor family of transcription factors, plays a crucial role not only in the development of the male phenotype but...
4.
Harikumar H, van Royen M, van Leenders G
Histopathology . 2024 Oct; 86(5):681-693. PMID: 39428716
The Gleason score is the gold standard for grading of prostate cancer (PCa) and is assessed by assigning specific grades to different microscopical growth patterns. Aside from the Gleason grades,...
5.
van Leeuwen L, Shamier M, Verstrepen B, Gotz H, Schmitz K, Akhiyate N, et al.
Euro Surveill . 2024 Sep; 29(38). PMID: 39301741
In response to the mpox outbreak in 2022 and 2023, widespread vaccination with modified vaccinia Ankara-Bavarian Nordic (MVA-BN, also known as JYNNEOS or Imvanex) was initiated. Here, we demonstrate that...
6.
Shamier M, Zaeck L, Gotz H, Vieyra B, Verstrepen B, Wijnans K, et al.
Euro Surveill . 2024 Apr; 29(17). PMID: 38666400
BackgroundFollowing the 2022-2023 mpox outbreak, crucial knowledge gaps exist regarding orthopoxvirus-specific immunity in risk groups and its impact on future outbreaks.AimWe combined cross-sectional seroprevalence studies in two cities in the...
7.
Carreras Mascaro A, Grochowska M, Boumeester V, Dits N, Bilgi E, Breedveld G, et al.
Cell Mol Life Sci . 2024 Feb; 81(1):75. PMID: 38315424
Autosomal dominant variants in LRP10 have been identified in patients with Lewy body diseases (LBDs), including Parkinson's disease (PD), Parkinson's disease-dementia (PDD), and dementia with Lewy bodies (DLB). Nevertheless, there...
8.
Buck S, Van Hemelryk A, de Ridder C, Stuurman D, Erkens-Schulze S, van t Geloof S, et al.
Mol Cancer Ther . 2023 Nov; 23(5):711-720. PMID: 38030379
Resistance to taxane chemotherapy is frequently observed in metastatic prostate cancer. The androgen receptor (AR) is a major driver of prostate cancer and a key regulator of the G1-S cell-cycle...
9.
Yavuz S, Kabbech H, van Staalduinen J, Linder S, van Cappellen W, Nigg A, et al.
Nucleic Acids Res . 2023 Oct; 51(20):10992-11009. PMID: 37791849
A wide range of nuclear proteins are involved in the spatio-temporal organization of the genome through diverse biological processes such as gene transcription and DNA replication. Upon stimulation by testosterone...
10.
Mykytyn A, Breugem T, Geurts M, Beumer J, Schipper D, van Acker R, et al.
J Virol . 2023 Aug; 97(8):e0085123. PMID: 37555660
SARS-CoV-2 can enter cells after its spike protein is cleaved by either type II transmembrane serine proteases (TTSPs), like TMPRSS2, or cathepsins. It is now widely accepted that the Omicron...